Back to search
Adenocarcinoma of the Rectum
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Adenocarcinoma of the Rectum trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Adenocarcinoma of the Rectum trials you may qualify forThis trial examines colorectal cancer incidence in participants with 1 to 2 non-advanced adenomas randomized to surveillance colonoscopy at 10 years compared to…
This is a prospective, open-label, randomized, parallel-group phase II trial evaluating the efficacy and safety of a low-dose radiotherapy sensitization strateg…
The purpose of this study is to find out whether the combination of botensilimab and balstilimab (BOT/BAL) is a safe and effective treatment that causes few or…
Researchers are looking for other ways to treat locally advanced or metastatic colorectal cancer (mCRC) that is unresectable and has a gene mutation called KRAS…
Neoadjuvant fluoropyrimidine-based chemoradiotherapy followed by total mesorectal excision (TME) is the standard of care for locally advanced rectal cancer (LAR…
This study evaluates whether images taken using a photon counting detector CT scanner (PCD-CT) can determine the growth of rectal cancer as well as, or better t…
This study investigates changes in physical measures of pelvic health and patient-reported outcomes of sexual function, intimate relationship, and quality of li…
Determine the complete pathologic complete response (pCR) rate in patients with locally advanced rectal adenocarcinoma.